CG
CNCR
Colony Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $208K | Buy |
18,983
+50
| +0.3% | +$548 | ﹤0.01% | 722 |
|
|
2023
Q2 | $245K | Buy |
+18,933
| New | +$245K | ﹤0.01% | 708 |
|
|
2023
Q1 | – | Sell |
-17,598
| Closed | -$242K | – | 796 |
|
|
2022
Q4 | $242K | Buy |
+17,598
| New | +$242K | ﹤0.01% | 753 |
|
|
2022
Q3 | – | Sell |
-20,892
| Closed | -$317K | – | 785 |
|
|
2022
Q2 | $317K | Buy |
20,892
+2,720
| +15% | +$41.3K | 0.01% | 680 |
|
|
2022
Q1 | $327K | Buy |
+18,172
| New | +$327K | ﹤0.01% | 704 |
|